Fighting Covid-19 with local innovations
More players in the biomedical sector are looking to expand their operations beyond R&D to small-to-medium-scale manufacturing.
AS the Covid-19 pandemic continues to rage around the globe, local small and medium-sized enterprises (SMEs) are meeting demand for diagnosis, treatment and protection solutions with homegrown innovations.
One of these companies, Gill Lab, took an unusual approach to balancing the demand and supply of surgical masks. Instead of setting up yet another mask manufacturing facility, it designed a reusable respirator that can extend the use of a surgical mask by up to six times. More than 100,000 units of the Gill Mask have already been sold worldwide since its launch in April.
Two others, Star Array and Lion TCR, are using capabilities in rapid testing technologies and virus treatments respectively to aid in testing and potentially treating the disease.
TRENDING NOW
Singapore developer in limbo after Timor-Leste scraps major township project
Troubled platform UCars founded by group of dealers wound up on S$4 million debt
On the board but frozen out: The Taib family feud tearing Sarawak construction giant apart
That ‘cheap’ Malaysia condo could cost Singapore buyers far more than they think